Global Live Brucellosis Vaccine Market Growth 2026-2032
The global Live Brucellosis Vaccine market size is predicted to grow from US$ 196 million in 2025 to US$ 263 million in 2032; it is expected to grow at a CAGR of 4.4% from 2026 to 2032.
Live Brucellosis Vaccine is a kind of vaccine used to prevent brucellosis, which is also known as Malta fever or undulant fever. It is a live attenuated vaccine prepared from weakened strains of Brucella bacteria. The attenuated Brucella strains in the live vaccine still retain certain antigenicity, which can stimulate the body's immune system to produce a relatively strong immune response, inducing the production of specific antibodies and cell-mediated immune responses, thereby providing effective protection for the body to prevent the occurrence of brucellosis. The attenuated strains in the live vaccine can replicate to a limited extent in the body, allowing the body's immune system to be continuously stimulated by antigens, resulting in more long-lasting immunity and extending the duration of immune protection.
United States market for Live Brucellosis Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Live Brucellosis Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Live Brucellosis Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Live Brucellosis Vaccine players cover CZ Vaccines, MSD, Ceva, Colorado Serum, Tecnovax, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Live Brucellosis Vaccine Industry Forecast? looks at past sales and reviews total world Live Brucellosis Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Live Brucellosis Vaccine sales for 2026 through 2032. With Live Brucellosis Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Live Brucellosis Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Live Brucellosis Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Live Brucellosis Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Live Brucellosis Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Live Brucellosis Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Live Brucellosis Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Live Brucellosis Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Live Brucellosis Vaccine market?
What factors are driving Live Brucellosis Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Live Brucellosis Vaccine market opportunities vary by end market size?
How does Live Brucellosis Vaccine break out by Type, by Application?
Live Brucellosis Vaccine is a kind of vaccine used to prevent brucellosis, which is also known as Malta fever or undulant fever. It is a live attenuated vaccine prepared from weakened strains of Brucella bacteria. The attenuated Brucella strains in the live vaccine still retain certain antigenicity, which can stimulate the body's immune system to produce a relatively strong immune response, inducing the production of specific antibodies and cell-mediated immune responses, thereby providing effective protection for the body to prevent the occurrence of brucellosis. The attenuated strains in the live vaccine can replicate to a limited extent in the body, allowing the body's immune system to be continuously stimulated by antigens, resulting in more long-lasting immunity and extending the duration of immune protection.
United States market for Live Brucellosis Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Live Brucellosis Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Live Brucellosis Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Live Brucellosis Vaccine players cover CZ Vaccines, MSD, Ceva, Colorado Serum, Tecnovax, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Live Brucellosis Vaccine Industry Forecast? looks at past sales and reviews total world Live Brucellosis Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Live Brucellosis Vaccine sales for 2026 through 2032. With Live Brucellosis Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Live Brucellosis Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Live Brucellosis Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Live Brucellosis Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Live Brucellosis Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Live Brucellosis Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Live Brucellosis Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Live Brucellosis Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Strain RB-51
- Strain S19
- Strain S2
- Strain A19
- Strain Rev. I
- Cattle
- Sheep
- Pig
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- CZ Vaccines
- MSD
- Ceva
- Colorado Serum
- Tecnovax
- Syva
- Shchelkovo Biocombinat
- Jinyu Baoling
- Biovet
- CAVAC
- VETAL
- Indian Immunologicals
- Dollvet
- Hester Biosciences
- Qilu Animal Health
- Auleon Biologicals
What is the 10-year outlook for the global Live Brucellosis Vaccine market?
What factors are driving Live Brucellosis Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Live Brucellosis Vaccine market opportunities vary by end market size?
How does Live Brucellosis Vaccine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Live Brucellosis Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Live Brucellosis Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Live Brucellosis Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Live Brucellosis Vaccine Segment by Type
2.2.1 Strain RB-51
2.2.2 Strain S19
2.2.3 Strain S2
2.2.4 Strain A19
2.2.5 Strain Rev. I
2.2.6 Live Brucellosis Vaccine Sales by Type
2.2.6.1 Global Live Brucellosis Vaccine Sales Market Share by Type (2021-2026)
2.2.6.2 Global Live Brucellosis Vaccine Revenue and Market Share by Type (2021-2026)
2.2.6.3 Global Live Brucellosis Vaccine Sale Price by Type (2021-2026)
2.3 Live Brucellosis Vaccine Segment by Application
2.3.1 Cattle
2.3.2 Sheep
2.3.3 Pig
2.3.4 Others
2.3.5 Live Brucellosis Vaccine Sales by Application
2.3.5.1 Global Live Brucellosis Vaccine Sale Market Share by Application (2021-2026)
2.3.5.2 Global Live Brucellosis Vaccine Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global Live Brucellosis Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Live Brucellosis Vaccine Breakdown Data by Company
3.1.1 Global Live Brucellosis Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Live Brucellosis Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Live Brucellosis Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Live Brucellosis Vaccine Revenue by Company (2021-2026)
3.2.2 Global Live Brucellosis Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Live Brucellosis Vaccine Sale Price by Company
3.4 Key Manufacturers Live Brucellosis Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Live Brucellosis Vaccine Product Location Distribution
3.4.2 Players Live Brucellosis Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR LIVE BRUCELLOSIS VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Live Brucellosis Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Live Brucellosis Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Live Brucellosis Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Live Brucellosis Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Live Brucellosis Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Live Brucellosis Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Live Brucellosis Vaccine Sales Growth
4.4 APAC Live Brucellosis Vaccine Sales Growth
4.5 Europe Live Brucellosis Vaccine Sales Growth
4.6 Middle East & Africa Live Brucellosis Vaccine Sales Growth
5 AMERICAS
5.1 Americas Live Brucellosis Vaccine Sales by Country
5.1.1 Americas Live Brucellosis Vaccine Sales by Country (2021-2026)
5.1.2 Americas Live Brucellosis Vaccine Revenue by Country (2021-2026)
5.2 Americas Live Brucellosis Vaccine Sales by Type (2021-2026)
5.3 Americas Live Brucellosis Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Live Brucellosis Vaccine Sales by Region
6.1.1 APAC Live Brucellosis Vaccine Sales by Region (2021-2026)
6.1.2 APAC Live Brucellosis Vaccine Revenue by Region (2021-2026)
6.2 APAC Live Brucellosis Vaccine Sales by Type (2021-2026)
6.3 APAC Live Brucellosis Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Live Brucellosis Vaccine by Country
7.1.1 Europe Live Brucellosis Vaccine Sales by Country (2021-2026)
7.1.2 Europe Live Brucellosis Vaccine Revenue by Country (2021-2026)
7.2 Europe Live Brucellosis Vaccine Sales by Type (2021-2026)
7.3 Europe Live Brucellosis Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Live Brucellosis Vaccine by Country
8.1.1 Middle East & Africa Live Brucellosis Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Live Brucellosis Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Live Brucellosis Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Live Brucellosis Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Live Brucellosis Vaccine
10.3 Manufacturing Process Analysis of Live Brucellosis Vaccine
10.4 Industry Chain Structure of Live Brucellosis Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Live Brucellosis Vaccine Distributors
11.3 Live Brucellosis Vaccine Customer
12 WORLD FORECAST REVIEW FOR LIVE BRUCELLOSIS VACCINE BY GEOGRAPHIC REGION
12.1 Global Live Brucellosis Vaccine Market Size Forecast by Region
12.1.1 Global Live Brucellosis Vaccine Forecast by Region (2027-2032)
12.1.2 Global Live Brucellosis Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Live Brucellosis Vaccine Forecast by Type (2027-2032)
12.7 Global Live Brucellosis Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 CZ Vaccines
13.1.1 CZ Vaccines Company Information
13.1.2 CZ Vaccines Live Brucellosis Vaccine Product Portfolios and Specifications
13.1.3 CZ Vaccines Live Brucellosis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 CZ Vaccines Main Business Overview
13.1.5 CZ Vaccines Latest Developments
13.2 MSD
13.2.1 MSD Company Information
13.2.2 MSD Live Brucellosis Vaccine Product Portfolios and Specifications
13.2.3 MSD Live Brucellosis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 MSD Main Business Overview
13.2.5 MSD Latest Developments
13.3 Ceva
13.3.1 Ceva Company Information
13.3.2 Ceva Live Brucellosis Vaccine Product Portfolios and Specifications
13.3.3 Ceva Live Brucellosis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Ceva Main Business Overview
13.3.5 Ceva Latest Developments
13.4 Colorado Serum
13.4.1 Colorado Serum Company Information
13.4.2 Colorado Serum Live Brucellosis Vaccine Product Portfolios and Specifications
13.4.3 Colorado Serum Live Brucellosis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Colorado Serum Main Business Overview
13.4.5 Colorado Serum Latest Developments
13.5 Tecnovax
13.5.1 Tecnovax Company Information
13.5.2 Tecnovax Live Brucellosis Vaccine Product Portfolios and Specifications
13.5.3 Tecnovax Live Brucellosis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Tecnovax Main Business Overview
13.5.5 Tecnovax Latest Developments
13.6 Syva
13.6.1 Syva Company Information
13.6.2 Syva Live Brucellosis Vaccine Product Portfolios and Specifications
13.6.3 Syva Live Brucellosis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Syva Main Business Overview
13.6.5 Syva Latest Developments
13.7 Shchelkovo Biocombinat
13.7.1 Shchelkovo Biocombinat Company Information
13.7.2 Shchelkovo Biocombinat Live Brucellosis Vaccine Product Portfolios and Specifications
13.7.3 Shchelkovo Biocombinat Live Brucellosis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Shchelkovo Biocombinat Main Business Overview
13.7.5 Shchelkovo Biocombinat Latest Developments
13.8 Jinyu Baoling
13.8.1 Jinyu Baoling Company Information
13.8.2 Jinyu Baoling Live Brucellosis Vaccine Product Portfolios and Specifications
13.8.3 Jinyu Baoling Live Brucellosis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Jinyu Baoling Main Business Overview
13.8.5 Jinyu Baoling Latest Developments
13.9 Biovet
13.9.1 Biovet Company Information
13.9.2 Biovet Live Brucellosis Vaccine Product Portfolios and Specifications
13.9.3 Biovet Live Brucellosis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Biovet Main Business Overview
13.9.5 Biovet Latest Developments
13.10 CAVAC
13.10.1 CAVAC Company Information
13.10.2 CAVAC Live Brucellosis Vaccine Product Portfolios and Specifications
13.10.3 CAVAC Live Brucellosis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 CAVAC Main Business Overview
13.10.5 CAVAC Latest Developments
13.11 VETAL
13.11.1 VETAL Company Information
13.11.2 VETAL Live Brucellosis Vaccine Product Portfolios and Specifications
13.11.3 VETAL Live Brucellosis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 VETAL Main Business Overview
13.11.5 VETAL Latest Developments
13.12 Indian Immunologicals
13.12.1 Indian Immunologicals Company Information
13.12.2 Indian Immunologicals Live Brucellosis Vaccine Product Portfolios and Specifications
13.12.3 Indian Immunologicals Live Brucellosis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Indian Immunologicals Main Business Overview
13.12.5 Indian Immunologicals Latest Developments
13.13 Dollvet
13.13.1 Dollvet Company Information
13.13.2 Dollvet Live Brucellosis Vaccine Product Portfolios and Specifications
13.13.3 Dollvet Live Brucellosis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Dollvet Main Business Overview
13.13.5 Dollvet Latest Developments
13.14 Hester Biosciences
13.14.1 Hester Biosciences Company Information
13.14.2 Hester Biosciences Live Brucellosis Vaccine Product Portfolios and Specifications
13.14.3 Hester Biosciences Live Brucellosis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Hester Biosciences Main Business Overview
13.14.5 Hester Biosciences Latest Developments
13.15 Qilu Animal Health
13.15.1 Qilu Animal Health Company Information
13.15.2 Qilu Animal Health Live Brucellosis Vaccine Product Portfolios and Specifications
13.15.3 Qilu Animal Health Live Brucellosis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Qilu Animal Health Main Business Overview
13.15.5 Qilu Animal Health Latest Developments
13.16 Auleon Biologicals
13.16.1 Auleon Biologicals Company Information
13.16.2 Auleon Biologicals Live Brucellosis Vaccine Product Portfolios and Specifications
13.16.3 Auleon Biologicals Live Brucellosis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Auleon Biologicals Main Business Overview
13.16.5 Auleon Biologicals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Live Brucellosis Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Live Brucellosis Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Live Brucellosis Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Live Brucellosis Vaccine Segment by Type
2.2.1 Strain RB-51
2.2.2 Strain S19
2.2.3 Strain S2
2.2.4 Strain A19
2.2.5 Strain Rev. I
2.2.6 Live Brucellosis Vaccine Sales by Type
2.2.6.1 Global Live Brucellosis Vaccine Sales Market Share by Type (2021-2026)
2.2.6.2 Global Live Brucellosis Vaccine Revenue and Market Share by Type (2021-2026)
2.2.6.3 Global Live Brucellosis Vaccine Sale Price by Type (2021-2026)
2.3 Live Brucellosis Vaccine Segment by Application
2.3.1 Cattle
2.3.2 Sheep
2.3.3 Pig
2.3.4 Others
2.3.5 Live Brucellosis Vaccine Sales by Application
2.3.5.1 Global Live Brucellosis Vaccine Sale Market Share by Application (2021-2026)
2.3.5.2 Global Live Brucellosis Vaccine Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global Live Brucellosis Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Live Brucellosis Vaccine Breakdown Data by Company
3.1.1 Global Live Brucellosis Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Live Brucellosis Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Live Brucellosis Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Live Brucellosis Vaccine Revenue by Company (2021-2026)
3.2.2 Global Live Brucellosis Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Live Brucellosis Vaccine Sale Price by Company
3.4 Key Manufacturers Live Brucellosis Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Live Brucellosis Vaccine Product Location Distribution
3.4.2 Players Live Brucellosis Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR LIVE BRUCELLOSIS VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Live Brucellosis Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Live Brucellosis Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Live Brucellosis Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Live Brucellosis Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Live Brucellosis Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Live Brucellosis Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Live Brucellosis Vaccine Sales Growth
4.4 APAC Live Brucellosis Vaccine Sales Growth
4.5 Europe Live Brucellosis Vaccine Sales Growth
4.6 Middle East & Africa Live Brucellosis Vaccine Sales Growth
5 AMERICAS
5.1 Americas Live Brucellosis Vaccine Sales by Country
5.1.1 Americas Live Brucellosis Vaccine Sales by Country (2021-2026)
5.1.2 Americas Live Brucellosis Vaccine Revenue by Country (2021-2026)
5.2 Americas Live Brucellosis Vaccine Sales by Type (2021-2026)
5.3 Americas Live Brucellosis Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Live Brucellosis Vaccine Sales by Region
6.1.1 APAC Live Brucellosis Vaccine Sales by Region (2021-2026)
6.1.2 APAC Live Brucellosis Vaccine Revenue by Region (2021-2026)
6.2 APAC Live Brucellosis Vaccine Sales by Type (2021-2026)
6.3 APAC Live Brucellosis Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Live Brucellosis Vaccine by Country
7.1.1 Europe Live Brucellosis Vaccine Sales by Country (2021-2026)
7.1.2 Europe Live Brucellosis Vaccine Revenue by Country (2021-2026)
7.2 Europe Live Brucellosis Vaccine Sales by Type (2021-2026)
7.3 Europe Live Brucellosis Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Live Brucellosis Vaccine by Country
8.1.1 Middle East & Africa Live Brucellosis Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Live Brucellosis Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Live Brucellosis Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Live Brucellosis Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Live Brucellosis Vaccine
10.3 Manufacturing Process Analysis of Live Brucellosis Vaccine
10.4 Industry Chain Structure of Live Brucellosis Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Live Brucellosis Vaccine Distributors
11.3 Live Brucellosis Vaccine Customer
12 WORLD FORECAST REVIEW FOR LIVE BRUCELLOSIS VACCINE BY GEOGRAPHIC REGION
12.1 Global Live Brucellosis Vaccine Market Size Forecast by Region
12.1.1 Global Live Brucellosis Vaccine Forecast by Region (2027-2032)
12.1.2 Global Live Brucellosis Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Live Brucellosis Vaccine Forecast by Type (2027-2032)
12.7 Global Live Brucellosis Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 CZ Vaccines
13.1.1 CZ Vaccines Company Information
13.1.2 CZ Vaccines Live Brucellosis Vaccine Product Portfolios and Specifications
13.1.3 CZ Vaccines Live Brucellosis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 CZ Vaccines Main Business Overview
13.1.5 CZ Vaccines Latest Developments
13.2 MSD
13.2.1 MSD Company Information
13.2.2 MSD Live Brucellosis Vaccine Product Portfolios and Specifications
13.2.3 MSD Live Brucellosis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 MSD Main Business Overview
13.2.5 MSD Latest Developments
13.3 Ceva
13.3.1 Ceva Company Information
13.3.2 Ceva Live Brucellosis Vaccine Product Portfolios and Specifications
13.3.3 Ceva Live Brucellosis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Ceva Main Business Overview
13.3.5 Ceva Latest Developments
13.4 Colorado Serum
13.4.1 Colorado Serum Company Information
13.4.2 Colorado Serum Live Brucellosis Vaccine Product Portfolios and Specifications
13.4.3 Colorado Serum Live Brucellosis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Colorado Serum Main Business Overview
13.4.5 Colorado Serum Latest Developments
13.5 Tecnovax
13.5.1 Tecnovax Company Information
13.5.2 Tecnovax Live Brucellosis Vaccine Product Portfolios and Specifications
13.5.3 Tecnovax Live Brucellosis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Tecnovax Main Business Overview
13.5.5 Tecnovax Latest Developments
13.6 Syva
13.6.1 Syva Company Information
13.6.2 Syva Live Brucellosis Vaccine Product Portfolios and Specifications
13.6.3 Syva Live Brucellosis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Syva Main Business Overview
13.6.5 Syva Latest Developments
13.7 Shchelkovo Biocombinat
13.7.1 Shchelkovo Biocombinat Company Information
13.7.2 Shchelkovo Biocombinat Live Brucellosis Vaccine Product Portfolios and Specifications
13.7.3 Shchelkovo Biocombinat Live Brucellosis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Shchelkovo Biocombinat Main Business Overview
13.7.5 Shchelkovo Biocombinat Latest Developments
13.8 Jinyu Baoling
13.8.1 Jinyu Baoling Company Information
13.8.2 Jinyu Baoling Live Brucellosis Vaccine Product Portfolios and Specifications
13.8.3 Jinyu Baoling Live Brucellosis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Jinyu Baoling Main Business Overview
13.8.5 Jinyu Baoling Latest Developments
13.9 Biovet
13.9.1 Biovet Company Information
13.9.2 Biovet Live Brucellosis Vaccine Product Portfolios and Specifications
13.9.3 Biovet Live Brucellosis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Biovet Main Business Overview
13.9.5 Biovet Latest Developments
13.10 CAVAC
13.10.1 CAVAC Company Information
13.10.2 CAVAC Live Brucellosis Vaccine Product Portfolios and Specifications
13.10.3 CAVAC Live Brucellosis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 CAVAC Main Business Overview
13.10.5 CAVAC Latest Developments
13.11 VETAL
13.11.1 VETAL Company Information
13.11.2 VETAL Live Brucellosis Vaccine Product Portfolios and Specifications
13.11.3 VETAL Live Brucellosis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 VETAL Main Business Overview
13.11.5 VETAL Latest Developments
13.12 Indian Immunologicals
13.12.1 Indian Immunologicals Company Information
13.12.2 Indian Immunologicals Live Brucellosis Vaccine Product Portfolios and Specifications
13.12.3 Indian Immunologicals Live Brucellosis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Indian Immunologicals Main Business Overview
13.12.5 Indian Immunologicals Latest Developments
13.13 Dollvet
13.13.1 Dollvet Company Information
13.13.2 Dollvet Live Brucellosis Vaccine Product Portfolios and Specifications
13.13.3 Dollvet Live Brucellosis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Dollvet Main Business Overview
13.13.5 Dollvet Latest Developments
13.14 Hester Biosciences
13.14.1 Hester Biosciences Company Information
13.14.2 Hester Biosciences Live Brucellosis Vaccine Product Portfolios and Specifications
13.14.3 Hester Biosciences Live Brucellosis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Hester Biosciences Main Business Overview
13.14.5 Hester Biosciences Latest Developments
13.15 Qilu Animal Health
13.15.1 Qilu Animal Health Company Information
13.15.2 Qilu Animal Health Live Brucellosis Vaccine Product Portfolios and Specifications
13.15.3 Qilu Animal Health Live Brucellosis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Qilu Animal Health Main Business Overview
13.15.5 Qilu Animal Health Latest Developments
13.16 Auleon Biologicals
13.16.1 Auleon Biologicals Company Information
13.16.2 Auleon Biologicals Live Brucellosis Vaccine Product Portfolios and Specifications
13.16.3 Auleon Biologicals Live Brucellosis Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Auleon Biologicals Main Business Overview
13.16.5 Auleon Biologicals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Live Brucellosis Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Live Brucellosis Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Strain RB-51
Table 4. Major Players of Strain S19
Table 5. Major Players of Strain S2
Table 6. Major Players of Strain A19
Table 7. Major Players of Strain Rev. I
Table 8. Global Live Brucellosis Vaccine Sales by Type (2021-2026) & (K Units)
Table 9. Global Live Brucellosis Vaccine Sales Market Share by Type (2021-2026)
Table 10. Global Live Brucellosis Vaccine Revenue by Type (2021-2026) & ($ million)
Table 11. Global Live Brucellosis Vaccine Revenue Market Share by Type (2021-2026)
Table 12. Global Live Brucellosis Vaccine Sale Price by Type (2021-2026) & (US$/Unit)
Table 13. Global Live Brucellosis Vaccine Sale by Application (2021-2026) & (K Units)
Table 14. Global Live Brucellosis Vaccine Sale Market Share by Application (2021-2026)
Table 15. Global Live Brucellosis Vaccine Revenue by Application (2021-2026) & ($ million)
Table 16. Global Live Brucellosis Vaccine Revenue Market Share by Application (2021-2026)
Table 17. Global Live Brucellosis Vaccine Sale Price by Application (2021-2026) & (US$/Unit)
Table 18. Global Live Brucellosis Vaccine Sales by Company (2021-2026) & (K Units)
Table 19. Global Live Brucellosis Vaccine Sales Market Share by Company (2021-2026)
Table 20. Global Live Brucellosis Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 21. Global Live Brucellosis Vaccine Revenue Market Share by Company (2021-2026)
Table 22. Global Live Brucellosis Vaccine Sale Price by Company (2021-2026) & (US$/Unit)
Table 23. Key Manufacturers Live Brucellosis Vaccine Producing Area Distribution and Sales Area
Table 24. Players Live Brucellosis Vaccine Products Offered
Table 25. Live Brucellosis Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Live Brucellosis Vaccine Sales by Geographic Region (2021-2026) & (K Units)
Table 29. Global Live Brucellosis Vaccine Sales Market Share Geographic Region (2021-2026)
Table 30. Global Live Brucellosis Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 31. Global Live Brucellosis Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 32. Global Live Brucellosis Vaccine Sales by Country/Region (2021-2026) & (K Units)
Table 33. Global Live Brucellosis Vaccine Sales Market Share by Country/Region (2021-2026)
Table 34. Global Live Brucellosis Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 35. Global Live Brucellosis Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 36. Americas Live Brucellosis Vaccine Sales by Country (2021-2026) & (K Units)
Table 37. Americas Live Brucellosis Vaccine Sales Market Share by Country (2021-2026)
Table 38. Americas Live Brucellosis Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 39. Americas Live Brucellosis Vaccine Sales by Type (2021-2026) & (K Units)
Table 40. Americas Live Brucellosis Vaccine Sales by Application (2021-2026) & (K Units)
Table 41. APAC Live Brucellosis Vaccine Sales by Region (2021-2026) & (K Units)
Table 42. APAC Live Brucellosis Vaccine Sales Market Share by Region (2021-2026)
Table 43. APAC Live Brucellosis Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 44. APAC Live Brucellosis Vaccine Sales by Type (2021-2026) & (K Units)
Table 45. APAC Live Brucellosis Vaccine Sales by Application (2021-2026) & (K Units)
Table 46. Europe Live Brucellosis Vaccine Sales by Country (2021-2026) & (K Units)
Table 47. Europe Live Brucellosis Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 48. Europe Live Brucellosis Vaccine Sales by Type (2021-2026) & (K Units)
Table 49. Europe Live Brucellosis Vaccine Sales by Application (2021-2026) & (K Units)
Table 50. Middle East & Africa Live Brucellosis Vaccine Sales by Country (2021-2026) & (K Units)
Table 51. Middle East & Africa Live Brucellosis Vaccine Revenue Market Share by Country (2021-2026)
Table 52. Middle East & Africa Live Brucellosis Vaccine Sales by Type (2021-2026) & (K Units)
Table 53. Middle East & Africa Live Brucellosis Vaccine Sales by Application (2021-2026) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Live Brucellosis Vaccine
Table 55. Key Market Challenges & Risks of Live Brucellosis Vaccine
Table 56. Key Industry Trends of Live Brucellosis Vaccine
Table 57. Live Brucellosis Vaccine Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Live Brucellosis Vaccine Distributors List
Table 60. Live Brucellosis Vaccine Customer List
Table 61. Global Live Brucellosis Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 62. Global Live Brucellosis Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 63. Americas Live Brucellosis Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 64. Americas Live Brucellosis Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 65. APAC Live Brucellosis Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 66. APAC Live Brucellosis Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 67. Europe Live Brucellosis Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Europe Live Brucellosis Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Middle East & Africa Live Brucellosis Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 70. Middle East & Africa Live Brucellosis Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 71. Global Live Brucellosis Vaccine Sales Forecast by Type (2027-2032) & (K Units)
Table 72. Global Live Brucellosis Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 73. Global Live Brucellosis Vaccine Sales Forecast by Application (2027-2032) & (K Units)
Table 74. Global Live Brucellosis Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 75. CZ Vaccines Basic Information, Live Brucellosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 76. CZ Vaccines Live Brucellosis Vaccine Product Portfolios and Specifications
Table 77. CZ Vaccines Live Brucellosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 78. CZ Vaccines Main Business
Table 79. CZ Vaccines Latest Developments
Table 80. MSD Basic Information, Live Brucellosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 81. MSD Live Brucellosis Vaccine Product Portfolios and Specifications
Table 82. MSD Live Brucellosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 83. MSD Main Business
Table 84. MSD Latest Developments
Table 85. Ceva Basic Information, Live Brucellosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 86. Ceva Live Brucellosis Vaccine Product Portfolios and Specifications
Table 87. Ceva Live Brucellosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 88. Ceva Main Business
Table 89. Ceva Latest Developments
Table 90. Colorado Serum Basic Information, Live Brucellosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 91. Colorado Serum Live Brucellosis Vaccine Product Portfolios and Specifications
Table 92. Colorado Serum Live Brucellosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. Colorado Serum Main Business
Table 94. Colorado Serum Latest Developments
Table 95. Tecnovax Basic Information, Live Brucellosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 96. Tecnovax Live Brucellosis Vaccine Product Portfolios and Specifications
Table 97. Tecnovax Live Brucellosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. Tecnovax Main Business
Table 99. Tecnovax Latest Developments
Table 100. Syva Basic Information, Live Brucellosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 101. Syva Live Brucellosis Vaccine Product Portfolios and Specifications
Table 102. Syva Live Brucellosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. Syva Main Business
Table 104. Syva Latest Developments
Table 105. Shchelkovo Biocombinat Basic Information, Live Brucellosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 106. Shchelkovo Biocombinat Live Brucellosis Vaccine Product Portfolios and Specifications
Table 107. Shchelkovo Biocombinat Live Brucellosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 108. Shchelkovo Biocombinat Main Business
Table 109. Shchelkovo Biocombinat Latest Developments
Table 110. Jinyu Baoling Basic Information, Live Brucellosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 111. Jinyu Baoling Live Brucellosis Vaccine Product Portfolios and Specifications
Table 112. Jinyu Baoling Live Brucellosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 113. Jinyu Baoling Main Business
Table 114. Jinyu Baoling Latest Developments
Table 115. Biovet Basic Information, Live Brucellosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 116. Biovet Live Brucellosis Vaccine Product Portfolios and Specifications
Table 117. Biovet Live Brucellosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 118. Biovet Main Business
Table 119. Biovet Latest Developments
Table 120. CAVAC Basic Information, Live Brucellosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 121. CAVAC Live Brucellosis Vaccine Product Portfolios and Specifications
Table 122. CAVAC Live Brucellosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 123. CAVAC Main Business
Table 124. CAVAC Latest Developments
Table 125. VETAL Basic Information, Live Brucellosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 126. VETAL Live Brucellosis Vaccine Product Portfolios and Specifications
Table 127. VETAL Live Brucellosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 128. VETAL Main Business
Table 129. VETAL Latest Developments
Table 130. Indian Immunologicals Basic Information, Live Brucellosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 131. Indian Immunologicals Live Brucellosis Vaccine Product Portfolios and Specifications
Table 132. Indian Immunologicals Live Brucellosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 133. Indian Immunologicals Main Business
Table 134. Indian Immunologicals Latest Developments
Table 135. Dollvet Basic Information, Live Brucellosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 136. Dollvet Live Brucellosis Vaccine Product Portfolios and Specifications
Table 137. Dollvet Live Brucellosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 138. Dollvet Main Business
Table 139. Dollvet Latest Developments
Table 140. Hester Biosciences Basic Information, Live Brucellosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 141. Hester Biosciences Live Brucellosis Vaccine Product Portfolios and Specifications
Table 142. Hester Biosciences Live Brucellosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 143. Hester Biosciences Main Business
Table 144. Hester Biosciences Latest Developments
Table 145. Qilu Animal Health Basic Information, Live Brucellosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 146. Qilu Animal Health Live Brucellosis Vaccine Product Portfolios and Specifications
Table 147. Qilu Animal Health Live Brucellosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 148. Qilu Animal Health Main Business
Table 149. Qilu Animal Health Latest Developments
Table 150. Auleon Biologicals Basic Information, Live Brucellosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 151. Auleon Biologicals Live Brucellosis Vaccine Product Portfolios and Specifications
Table 152. Auleon Biologicals Live Brucellosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 153. Auleon Biologicals Main Business
Table 154. Auleon Biologicals Latest Developments
Table 1. Live Brucellosis Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Live Brucellosis Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Strain RB-51
Table 4. Major Players of Strain S19
Table 5. Major Players of Strain S2
Table 6. Major Players of Strain A19
Table 7. Major Players of Strain Rev. I
Table 8. Global Live Brucellosis Vaccine Sales by Type (2021-2026) & (K Units)
Table 9. Global Live Brucellosis Vaccine Sales Market Share by Type (2021-2026)
Table 10. Global Live Brucellosis Vaccine Revenue by Type (2021-2026) & ($ million)
Table 11. Global Live Brucellosis Vaccine Revenue Market Share by Type (2021-2026)
Table 12. Global Live Brucellosis Vaccine Sale Price by Type (2021-2026) & (US$/Unit)
Table 13. Global Live Brucellosis Vaccine Sale by Application (2021-2026) & (K Units)
Table 14. Global Live Brucellosis Vaccine Sale Market Share by Application (2021-2026)
Table 15. Global Live Brucellosis Vaccine Revenue by Application (2021-2026) & ($ million)
Table 16. Global Live Brucellosis Vaccine Revenue Market Share by Application (2021-2026)
Table 17. Global Live Brucellosis Vaccine Sale Price by Application (2021-2026) & (US$/Unit)
Table 18. Global Live Brucellosis Vaccine Sales by Company (2021-2026) & (K Units)
Table 19. Global Live Brucellosis Vaccine Sales Market Share by Company (2021-2026)
Table 20. Global Live Brucellosis Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 21. Global Live Brucellosis Vaccine Revenue Market Share by Company (2021-2026)
Table 22. Global Live Brucellosis Vaccine Sale Price by Company (2021-2026) & (US$/Unit)
Table 23. Key Manufacturers Live Brucellosis Vaccine Producing Area Distribution and Sales Area
Table 24. Players Live Brucellosis Vaccine Products Offered
Table 25. Live Brucellosis Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Live Brucellosis Vaccine Sales by Geographic Region (2021-2026) & (K Units)
Table 29. Global Live Brucellosis Vaccine Sales Market Share Geographic Region (2021-2026)
Table 30. Global Live Brucellosis Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 31. Global Live Brucellosis Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 32. Global Live Brucellosis Vaccine Sales by Country/Region (2021-2026) & (K Units)
Table 33. Global Live Brucellosis Vaccine Sales Market Share by Country/Region (2021-2026)
Table 34. Global Live Brucellosis Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 35. Global Live Brucellosis Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 36. Americas Live Brucellosis Vaccine Sales by Country (2021-2026) & (K Units)
Table 37. Americas Live Brucellosis Vaccine Sales Market Share by Country (2021-2026)
Table 38. Americas Live Brucellosis Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 39. Americas Live Brucellosis Vaccine Sales by Type (2021-2026) & (K Units)
Table 40. Americas Live Brucellosis Vaccine Sales by Application (2021-2026) & (K Units)
Table 41. APAC Live Brucellosis Vaccine Sales by Region (2021-2026) & (K Units)
Table 42. APAC Live Brucellosis Vaccine Sales Market Share by Region (2021-2026)
Table 43. APAC Live Brucellosis Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 44. APAC Live Brucellosis Vaccine Sales by Type (2021-2026) & (K Units)
Table 45. APAC Live Brucellosis Vaccine Sales by Application (2021-2026) & (K Units)
Table 46. Europe Live Brucellosis Vaccine Sales by Country (2021-2026) & (K Units)
Table 47. Europe Live Brucellosis Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 48. Europe Live Brucellosis Vaccine Sales by Type (2021-2026) & (K Units)
Table 49. Europe Live Brucellosis Vaccine Sales by Application (2021-2026) & (K Units)
Table 50. Middle East & Africa Live Brucellosis Vaccine Sales by Country (2021-2026) & (K Units)
Table 51. Middle East & Africa Live Brucellosis Vaccine Revenue Market Share by Country (2021-2026)
Table 52. Middle East & Africa Live Brucellosis Vaccine Sales by Type (2021-2026) & (K Units)
Table 53. Middle East & Africa Live Brucellosis Vaccine Sales by Application (2021-2026) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Live Brucellosis Vaccine
Table 55. Key Market Challenges & Risks of Live Brucellosis Vaccine
Table 56. Key Industry Trends of Live Brucellosis Vaccine
Table 57. Live Brucellosis Vaccine Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Live Brucellosis Vaccine Distributors List
Table 60. Live Brucellosis Vaccine Customer List
Table 61. Global Live Brucellosis Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 62. Global Live Brucellosis Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 63. Americas Live Brucellosis Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 64. Americas Live Brucellosis Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 65. APAC Live Brucellosis Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 66. APAC Live Brucellosis Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 67. Europe Live Brucellosis Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Europe Live Brucellosis Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Middle East & Africa Live Brucellosis Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 70. Middle East & Africa Live Brucellosis Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 71. Global Live Brucellosis Vaccine Sales Forecast by Type (2027-2032) & (K Units)
Table 72. Global Live Brucellosis Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 73. Global Live Brucellosis Vaccine Sales Forecast by Application (2027-2032) & (K Units)
Table 74. Global Live Brucellosis Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 75. CZ Vaccines Basic Information, Live Brucellosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 76. CZ Vaccines Live Brucellosis Vaccine Product Portfolios and Specifications
Table 77. CZ Vaccines Live Brucellosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 78. CZ Vaccines Main Business
Table 79. CZ Vaccines Latest Developments
Table 80. MSD Basic Information, Live Brucellosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 81. MSD Live Brucellosis Vaccine Product Portfolios and Specifications
Table 82. MSD Live Brucellosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 83. MSD Main Business
Table 84. MSD Latest Developments
Table 85. Ceva Basic Information, Live Brucellosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 86. Ceva Live Brucellosis Vaccine Product Portfolios and Specifications
Table 87. Ceva Live Brucellosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 88. Ceva Main Business
Table 89. Ceva Latest Developments
Table 90. Colorado Serum Basic Information, Live Brucellosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 91. Colorado Serum Live Brucellosis Vaccine Product Portfolios and Specifications
Table 92. Colorado Serum Live Brucellosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. Colorado Serum Main Business
Table 94. Colorado Serum Latest Developments
Table 95. Tecnovax Basic Information, Live Brucellosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 96. Tecnovax Live Brucellosis Vaccine Product Portfolios and Specifications
Table 97. Tecnovax Live Brucellosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. Tecnovax Main Business
Table 99. Tecnovax Latest Developments
Table 100. Syva Basic Information, Live Brucellosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 101. Syva Live Brucellosis Vaccine Product Portfolios and Specifications
Table 102. Syva Live Brucellosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. Syva Main Business
Table 104. Syva Latest Developments
Table 105. Shchelkovo Biocombinat Basic Information, Live Brucellosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 106. Shchelkovo Biocombinat Live Brucellosis Vaccine Product Portfolios and Specifications
Table 107. Shchelkovo Biocombinat Live Brucellosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 108. Shchelkovo Biocombinat Main Business
Table 109. Shchelkovo Biocombinat Latest Developments
Table 110. Jinyu Baoling Basic Information, Live Brucellosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 111. Jinyu Baoling Live Brucellosis Vaccine Product Portfolios and Specifications
Table 112. Jinyu Baoling Live Brucellosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 113. Jinyu Baoling Main Business
Table 114. Jinyu Baoling Latest Developments
Table 115. Biovet Basic Information, Live Brucellosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 116. Biovet Live Brucellosis Vaccine Product Portfolios and Specifications
Table 117. Biovet Live Brucellosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 118. Biovet Main Business
Table 119. Biovet Latest Developments
Table 120. CAVAC Basic Information, Live Brucellosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 121. CAVAC Live Brucellosis Vaccine Product Portfolios and Specifications
Table 122. CAVAC Live Brucellosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 123. CAVAC Main Business
Table 124. CAVAC Latest Developments
Table 125. VETAL Basic Information, Live Brucellosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 126. VETAL Live Brucellosis Vaccine Product Portfolios and Specifications
Table 127. VETAL Live Brucellosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 128. VETAL Main Business
Table 129. VETAL Latest Developments
Table 130. Indian Immunologicals Basic Information, Live Brucellosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 131. Indian Immunologicals Live Brucellosis Vaccine Product Portfolios and Specifications
Table 132. Indian Immunologicals Live Brucellosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 133. Indian Immunologicals Main Business
Table 134. Indian Immunologicals Latest Developments
Table 135. Dollvet Basic Information, Live Brucellosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 136. Dollvet Live Brucellosis Vaccine Product Portfolios and Specifications
Table 137. Dollvet Live Brucellosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 138. Dollvet Main Business
Table 139. Dollvet Latest Developments
Table 140. Hester Biosciences Basic Information, Live Brucellosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 141. Hester Biosciences Live Brucellosis Vaccine Product Portfolios and Specifications
Table 142. Hester Biosciences Live Brucellosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 143. Hester Biosciences Main Business
Table 144. Hester Biosciences Latest Developments
Table 145. Qilu Animal Health Basic Information, Live Brucellosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 146. Qilu Animal Health Live Brucellosis Vaccine Product Portfolios and Specifications
Table 147. Qilu Animal Health Live Brucellosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 148. Qilu Animal Health Main Business
Table 149. Qilu Animal Health Latest Developments
Table 150. Auleon Biologicals Basic Information, Live Brucellosis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 151. Auleon Biologicals Live Brucellosis Vaccine Product Portfolios and Specifications
Table 152. Auleon Biologicals Live Brucellosis Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 153. Auleon Biologicals Main Business
Table 154. Auleon Biologicals Latest Developments
LIST OF FIGURES
Figure 1. Picture of Live Brucellosis Vaccine
Figure 2. Live Brucellosis Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Live Brucellosis Vaccine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Live Brucellosis Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Live Brucellosis Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Live Brucellosis Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Live Brucellosis Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Strain RB-51
Figure 12. Product Picture of Strain S19
Figure 13. Product Picture of Strain S2
Figure 14. Product Picture of Strain A19
Figure 15. Product Picture of Strain Rev. I
Figure 16. Global Live Brucellosis Vaccine Sales Market Share by Type in 2026
Figure 17. Global Live Brucellosis Vaccine Revenue Market Share by Type (2021-2026)
Figure 18. Live Brucellosis Vaccine Consumed in Cattle
Figure 19. Global Live Brucellosis Vaccine Market: Cattle (2021-2026) & (K Units)
Figure 20. Live Brucellosis Vaccine Consumed in Sheep
Figure 21. Global Live Brucellosis Vaccine Market: Sheep (2021-2026) & (K Units)
Figure 22. Live Brucellosis Vaccine Consumed in Pig
Figure 23. Global Live Brucellosis Vaccine Market: Pig (2021-2026) & (K Units)
Figure 24. Live Brucellosis Vaccine Consumed in Others
Figure 25. Global Live Brucellosis Vaccine Market: Others (2021-2026) & (K Units)
Figure 26. Global Live Brucellosis Vaccine Sale Market Share by Application (2025)
Figure 27. Global Live Brucellosis Vaccine Revenue Market Share by Application in 2026
Figure 28. Live Brucellosis Vaccine Sales by Company in 2026 (K Units)
Figure 29. Global Live Brucellosis Vaccine Sales Market Share by Company in 2026
Figure 30. Live Brucellosis Vaccine Revenue by Company in 2026 ($ millions)
Figure 31. Global Live Brucellosis Vaccine Revenue Market Share by Company in 2026
Figure 32. Global Live Brucellosis Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 33. Global Live Brucellosis Vaccine Revenue Market Share by Geographic Region in 2026
Figure 34. Americas Live Brucellosis Vaccine Sales 2021-2026 (K Units)
Figure 35. Americas Live Brucellosis Vaccine Revenue 2021-2026 ($ millions)
Figure 36. APAC Live Brucellosis Vaccine Sales 2021-2026 (K Units)
Figure 37. APAC Live Brucellosis Vaccine Revenue 2021-2026 ($ millions)
Figure 38. Europe Live Brucellosis Vaccine Sales 2021-2026 (K Units)
Figure 39. Europe Live Brucellosis Vaccine Revenue 2021-2026 ($ millions)
Figure 40. Middle East & Africa Live Brucellosis Vaccine Sales 2021-2026 (K Units)
Figure 41. Middle East & Africa Live Brucellosis Vaccine Revenue 2021-2026 ($ millions)
Figure 42. Americas Live Brucellosis Vaccine Sales Market Share by Country in 2026
Figure 43. Americas Live Brucellosis Vaccine Revenue Market Share by Country (2021-2026)
Figure 44. Americas Live Brucellosis Vaccine Sales Market Share by Type (2021-2026)
Figure 45. Americas Live Brucellosis Vaccine Sales Market Share by Application (2021-2026)
Figure 46. United States Live Brucellosis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 47. Canada Live Brucellosis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 48. Mexico Live Brucellosis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 49. Brazil Live Brucellosis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 50. APAC Live Brucellosis Vaccine Sales Market Share by Region in 2026
Figure 51. APAC Live Brucellosis Vaccine Revenue Market Share by Region (2021-2026)
Figure 52. APAC Live Brucellosis Vaccine Sales Market Share by Type (2021-2026)
Figure 53. APAC Live Brucellosis Vaccine Sales Market Share by Application (2021-2026)
Figure 54. China Live Brucellosis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 55. Japan Live Brucellosis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 56. South Korea Live Brucellosis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 57. Southeast Asia Live Brucellosis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 58. India Live Brucellosis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 59. Australia Live Brucellosis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 60. China Taiwan Live Brucellosis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. Europe Live Brucellosis Vaccine Sales Market Share by Country in 2026
Figure 62. Europe Live Brucellosis Vaccine Revenue Market Share by Country (2021-2026)
Figure 63. Europe Live Brucellosis Vaccine Sales Market Share by Type (2021-2026)
Figure 64. Europe Live Brucellosis Vaccine Sales Market Share by Application (2021-2026)
Figure 65. Germany Live Brucellosis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 66. France Live Brucellosis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 67. UK Live Brucellosis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 68. Italy Live Brucellosis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 69. Russia Live Brucellosis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. Middle East & Africa Live Brucellosis Vaccine Sales Market Share by Country (2021-2026)
Figure 71. Middle East & Africa Live Brucellosis Vaccine Sales Market Share by Type (2021-2026)
Figure 72. Middle East & Africa Live Brucellosis Vaccine Sales Market Share by Application (2021-2026)
Figure 73. Egypt Live Brucellosis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 74. South Africa Live Brucellosis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 75. Israel Live Brucellosis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 76. Turkey Live Brucellosis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 77. GCC Countries Live Brucellosis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 78. Manufacturing Cost Structure Analysis of Live Brucellosis Vaccine in 2026
Figure 79. Manufacturing Process Analysis of Live Brucellosis Vaccine
Figure 80. Industry Chain Structure of Live Brucellosis Vaccine
Figure 81. Channels of Distribution
Figure 82. Global Live Brucellosis Vaccine Sales Market Forecast by Region (2027-2032)
Figure 83. Global Live Brucellosis Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 84. Global Live Brucellosis Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 85. Global Live Brucellosis Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 86. Global Live Brucellosis Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 87. Global Live Brucellosis Vaccine Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Live Brucellosis Vaccine
Figure 2. Live Brucellosis Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Live Brucellosis Vaccine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Live Brucellosis Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Live Brucellosis Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Live Brucellosis Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Live Brucellosis Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Strain RB-51
Figure 12. Product Picture of Strain S19
Figure 13. Product Picture of Strain S2
Figure 14. Product Picture of Strain A19
Figure 15. Product Picture of Strain Rev. I
Figure 16. Global Live Brucellosis Vaccine Sales Market Share by Type in 2026
Figure 17. Global Live Brucellosis Vaccine Revenue Market Share by Type (2021-2026)
Figure 18. Live Brucellosis Vaccine Consumed in Cattle
Figure 19. Global Live Brucellosis Vaccine Market: Cattle (2021-2026) & (K Units)
Figure 20. Live Brucellosis Vaccine Consumed in Sheep
Figure 21. Global Live Brucellosis Vaccine Market: Sheep (2021-2026) & (K Units)
Figure 22. Live Brucellosis Vaccine Consumed in Pig
Figure 23. Global Live Brucellosis Vaccine Market: Pig (2021-2026) & (K Units)
Figure 24. Live Brucellosis Vaccine Consumed in Others
Figure 25. Global Live Brucellosis Vaccine Market: Others (2021-2026) & (K Units)
Figure 26. Global Live Brucellosis Vaccine Sale Market Share by Application (2025)
Figure 27. Global Live Brucellosis Vaccine Revenue Market Share by Application in 2026
Figure 28. Live Brucellosis Vaccine Sales by Company in 2026 (K Units)
Figure 29. Global Live Brucellosis Vaccine Sales Market Share by Company in 2026
Figure 30. Live Brucellosis Vaccine Revenue by Company in 2026 ($ millions)
Figure 31. Global Live Brucellosis Vaccine Revenue Market Share by Company in 2026
Figure 32. Global Live Brucellosis Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 33. Global Live Brucellosis Vaccine Revenue Market Share by Geographic Region in 2026
Figure 34. Americas Live Brucellosis Vaccine Sales 2021-2026 (K Units)
Figure 35. Americas Live Brucellosis Vaccine Revenue 2021-2026 ($ millions)
Figure 36. APAC Live Brucellosis Vaccine Sales 2021-2026 (K Units)
Figure 37. APAC Live Brucellosis Vaccine Revenue 2021-2026 ($ millions)
Figure 38. Europe Live Brucellosis Vaccine Sales 2021-2026 (K Units)
Figure 39. Europe Live Brucellosis Vaccine Revenue 2021-2026 ($ millions)
Figure 40. Middle East & Africa Live Brucellosis Vaccine Sales 2021-2026 (K Units)
Figure 41. Middle East & Africa Live Brucellosis Vaccine Revenue 2021-2026 ($ millions)
Figure 42. Americas Live Brucellosis Vaccine Sales Market Share by Country in 2026
Figure 43. Americas Live Brucellosis Vaccine Revenue Market Share by Country (2021-2026)
Figure 44. Americas Live Brucellosis Vaccine Sales Market Share by Type (2021-2026)
Figure 45. Americas Live Brucellosis Vaccine Sales Market Share by Application (2021-2026)
Figure 46. United States Live Brucellosis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 47. Canada Live Brucellosis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 48. Mexico Live Brucellosis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 49. Brazil Live Brucellosis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 50. APAC Live Brucellosis Vaccine Sales Market Share by Region in 2026
Figure 51. APAC Live Brucellosis Vaccine Revenue Market Share by Region (2021-2026)
Figure 52. APAC Live Brucellosis Vaccine Sales Market Share by Type (2021-2026)
Figure 53. APAC Live Brucellosis Vaccine Sales Market Share by Application (2021-2026)
Figure 54. China Live Brucellosis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 55. Japan Live Brucellosis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 56. South Korea Live Brucellosis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 57. Southeast Asia Live Brucellosis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 58. India Live Brucellosis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 59. Australia Live Brucellosis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 60. China Taiwan Live Brucellosis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. Europe Live Brucellosis Vaccine Sales Market Share by Country in 2026
Figure 62. Europe Live Brucellosis Vaccine Revenue Market Share by Country (2021-2026)
Figure 63. Europe Live Brucellosis Vaccine Sales Market Share by Type (2021-2026)
Figure 64. Europe Live Brucellosis Vaccine Sales Market Share by Application (2021-2026)
Figure 65. Germany Live Brucellosis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 66. France Live Brucellosis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 67. UK Live Brucellosis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 68. Italy Live Brucellosis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 69. Russia Live Brucellosis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. Middle East & Africa Live Brucellosis Vaccine Sales Market Share by Country (2021-2026)
Figure 71. Middle East & Africa Live Brucellosis Vaccine Sales Market Share by Type (2021-2026)
Figure 72. Middle East & Africa Live Brucellosis Vaccine Sales Market Share by Application (2021-2026)
Figure 73. Egypt Live Brucellosis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 74. South Africa Live Brucellosis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 75. Israel Live Brucellosis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 76. Turkey Live Brucellosis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 77. GCC Countries Live Brucellosis Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 78. Manufacturing Cost Structure Analysis of Live Brucellosis Vaccine in 2026
Figure 79. Manufacturing Process Analysis of Live Brucellosis Vaccine
Figure 80. Industry Chain Structure of Live Brucellosis Vaccine
Figure 81. Channels of Distribution
Figure 82. Global Live Brucellosis Vaccine Sales Market Forecast by Region (2027-2032)
Figure 83. Global Live Brucellosis Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 84. Global Live Brucellosis Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 85. Global Live Brucellosis Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 86. Global Live Brucellosis Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 87. Global Live Brucellosis Vaccine Revenue Market Share Forecast by Application (2027-2032)
